These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16142859)

  • 1. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
    Glossop JR; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
    Glossop JR; Nixon NB; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2003 Jul; 30(7):1406-9. PubMed ID: 12858434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
    Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
    J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.
    Mattey DL; Nixon N; Dawes PT; Kerr J
    Ann Rheum Dis; 2005 Aug; 64(8):1190-4. PubMed ID: 15695537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients.
    Hussein YM; Mohamed RH; Pasha HF; El-Shahawy EE; Alzahrani SS
    Cell Immunol; 2011; 271(1):192-6. PubMed ID: 21777909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
    Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ
    Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.
    Nikolaisen C; Figenschau Y; Nossent JC
    J Rheumatol; 2008 Mar; 35(3):380-6. PubMed ID: 18260177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF receptor I polymorphism is associated with persistent palindromic rheumatism.
    Lu LY; Keng HM; Chu JJ; Lin XT; Hsu CM; Sung PK
    Scand J Rheumatol; 2007; 36(4):278-84. PubMed ID: 17763205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity.
    Dieudé P; Petit E; Cailleau-Moindrault S; Osorio J; Pierlot C; Martinez M; Fauré S; Alibert O; Lasbleiz S; De Toma C; Bardin T; Prum B; Cornélis F;
    Arthritis Rheum; 2002 Aug; 46(8):2039-44. PubMed ID: 12209506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
    de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
    J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes.
    van der Helm-van Mil AH; Dieudé P; Schonkeren JJ; Cornélis F; Huizinga TW
    Rheumatology (Oxford); 2004 Oct; 43(10):1232-4. PubMed ID: 15252214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
    Lard LR; van Gaalen FA; Schonkeren JJ; Pieterman EJ; Stoeken G; Vos K; Nelissen RG; Westendorp RG; Hoeben RC; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Rheum; 2003 Jul; 48(7):1841-8. PubMed ID: 12847677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis.
    Perdigones N; Vigo AG; Lamas JR; Martínez A; Balsa A; Pascual-Salcedo D; de la Concha EG; Fernández-Gutiérrez B; Urcelay E
    Arthritis Rheum; 2010 Mar; 62(3):705-10. PubMed ID: 20187130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.
    Fabris M; Di Poi E; D'Elia A; Damante G; Sinigaglia L; Ferraccioli G
    J Rheumatol; 2002 Jan; 29(1):29-33. PubMed ID: 11824966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.